CAS 870281-82-6 appears in our catalog under these names: Idelalisib, CAL-101, >95% (HPLC), Idelalisib/ 99.94% (existing batch purity), CAL–101 (Idelalisib, GS–1101), Idelalisib 98%. Offered by: Chemat Brand, TRC, Mikromol, TargetMol, GLPBio. Available pack sizes: on request, 10mg, 50mg, 250mg, 5mg, 25mg, 100mg, 200mg.
Idelalisib is a member of the class of quinazolines that is 5-fluoro-3-phenylquinazolin-4-one in which the hydrogen at position 2 is replaced by a (1S)-1-(3H-purin-6-ylamino)propyl group. used for for the treatment of refractory indolent non-Hodgkin's lymphoma and relapsed chronic lymphocytic leukemia. It has a role as an antineoplastic agent, an EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor and an apoptosis inducer. It is a member of purines, an aromatic amine, an organofluorine compound, a member of quinazolines and a secondary amino compound.
Source: ChEBI
| Molecular formula | C22H18FN7O |
|---|---|
| Molecular weight | 415.4 g/mol |
| IUPAC name | 5-fluoro-3-phenyl-2-[(1S)-1-(7H-purin-6-ylamino)propyl]quinazolin-4-one |
| InChIKey | IFSDAJWBUCMOAH-HNNXBMFYSA-N |
| SMILES | CC[C@@H](C1=NC2=C(C(=CC=C2)F)C(=O)N1C3=CC=CC=C3)NC4=NC=NC5=C4NC=N5 |
Computed by PubChem (NCBI)